Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
long COVID, long Lyme/PTLDS (post-treatment Lyme disease syndrome) and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
Phase 3b open-label design, 751 adults with obesity but without T2D, randomized 1:1 to max tolerated dose of tirzepatide (10 or 15 mg) or max tolerated dose of semaglutide (1.7 or 2.4 mg) for 72 weeks, both on top of behavioral support
Why Choose NutraKey
Their Womens Clinical Health Team offers specialized support to healthcare providers
Patients report decreased appetite and fewer cravings for energy-dense foods
Abbreviations: AEMPS: Spanish Agency for Drugs and Medicinal Products
US$ 20.24
US$ 25.24
US$ 20.63
